VIVOS THERAPEUTICS, INC.
Last · NASDAQ$0.1727+0.0037 (+2.19%)stale · yahoo · 150h ago
MA10MA20MA50
Market cap$3.47M20.1M sh
P/E · TTM-0.1fwd -0.2 · eps -1.88 · loss
Beta6.09vs S&P 500
Div yield—annual · TTM
52w range
$0.1575$4.625
Volume7.4Msession
Issuer
Legal nameVIVOS THERAPEUTICS, INC.
HQUnited States (US)
ListingUS VVOS
ISINUS92859E2072
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0001716166
CIK0001716166
Websitewww.vivos.com
Employees270
AddressVivos Therapeutics, Inc. 7921 Southpark Plaza 80120, Littleton
Loading chart…
Upcoming earnings
MON.16NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.30
Est. revenue
5.5M
Press & signals
- GlobeNewswire
Vivos Therapeutics Announces Material Debt Reduction
- GlobeNewswire
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
- GlobeNewswire
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans